Skip to content

KTTAW PASITHEA THERAPEUTICS CORP

Follow

*W EXP 08/12/202 (warrant or right)

6 managers (6 13F filers) reported a position in KTTAW shares at 2024-09-30, 672,701 shares in all. 1 filer opened a position and 2 filers sold out during the quarter.

Managers
6
13F filers
6
New
1
Added
0
Reduced
1
Sold out
2
Shares held by filers
672,701

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q3 2024

Filers in the available 13F reports with a share position at 2024-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Kepos Capital LPin group Kepos Capital LP334,600$12K0.01%013F-HRTimelineGroup
Warberg Asset Management LLC263,001$9.18K<0.01%-15,68313F-HRTimeline
ARMISTICE CAPITAL, LLC50,000$1.75K<0.01%013F-HRTimeline
Marex Group Ltdin group Marex Group Ltd25,000$873<0.01%013F-HRTimelineGroup
CLEAR STREET LLC100$3<0.01%new13F-HR/ATimeline
CONCOURSE FINANCIAL GROUP SECURITIES, I…0$00%013F-HRTimelineValue filed as zero, left out of ratios. Amount filed as zero, left out of ratios.